Investigations for biomarkers in inflammatory diseases like rheumatoid arthritis during fasting and diet

Investigations for biomarkers in inflammatory diseases like rheumatoid arthritis during fasting and diet - BioFast

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014097

Enrollment

Registered

2018-11-16

Start date

2015-11-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M05 E88.9

Interventions

Group 1: Patients with rheumatoid arthritis will participate in a 7 day fasting according to Dr. Buchinger. Parameters determined will be DAS28, routine laboratory markers of inflammation and flowcyt

Eligibility

Sex/Gender

All

Age

18 Years to 79 Years

Inclusion criteria

Inclusion criteria: rheumatoid arthritis, active disease or metabolic syndrome, manifested

Exclusion criteria

Exclusion criteria: 1) gout or proven infectious arthritis; 2) psychiatric disease, which limits understanding of the investigation protocol (unable to give consent); 3) pregnancy and breastfeeding

Design outcomes

Primary

Measure	Time frame
Influence of fasting and diet on inflammation, especially reduction of monocyte activation	—

Secondary

Measure	Time frame
Establishment of immunological markers on immune cells, which are able to indicate reduction of inflammation in rheumatoid arthritis	—

Countries

Germany

Contacts

Public ContactThomas Häupl

Charité Campus Charité Mitte

thomas.haeupl@charite.de+49 30 450 513291

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 9, 2026